Allergan Biocell breast implants recall in Canada: cancer risk
In plain language
This recall involves Allergan Biocell breast implants sold in Canada. They are being recalled due to a rare but serious risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Health Canada intends to suspend the licences for these implants. Patients should speak with their healthcare professional about any concerns.
What to do
- Speak with your surgeon or healthcare professional about your breast implants.
- Conduct regular breast self-exams and see your healthcare professional for follow-up.
- Consult a healthcare professional if you experience unusual changes to your breasts.
- Do not remove implants if you have no signs or symptoms of BIA-ALCL without discussing with a healthcare professional.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Cancer risk (BIA-ALCL)
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Cancer risk (BIA-ALCL)
What should consumers do?
Speak with your surgeon or healthcare professional about your breast implants. Conduct regular breast self-exams and see your healthcare professional for follow-up. Consult a healthcare professional if you experience unusual changes to your breasts. Do not remove implants if you have no signs or symptoms of BIA-ALCL without discussing with a healthcare professional.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Cancer risk (BIA-ALCL)
When was this product recalled?
This product was recalled on April 4, 2019.
Is the Allergan brand affected by this recall?
Yes, Allergan products are affected by this recall. This recall involves Allergan Biocell breast implants sold in Canada. They are being recalled due to a rare but serious risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Health Canada intends to suspend the licences for these implants. Patients should speak with their healthcare professional about any concerns.